|
> If it’s the majority of the manufacturers they contacted, doesn’t that mean that there’s at least one that has exhausted their production? Could that one perhaps be the largest one, like Teva? Also, if any one doesn’t have enough, that increases the amount needed for legitimate patient needs for all the others: either (1) they all have enough for legitimate patient needs, or (2) none of them do. And, here’s the thing, if there are patients with prescriptions who aren’t able to get them, or are having to scramble to call around to different pharmacy chains with different contracted suppliers to find one that isn’t out and unable to restock the particular dosage capsule (because they aren’t fungible) of the particular drug they are prescribed, then, no, there aren’t enough for legitimate patient needs. “But some prescriptions are illegitimate” – maybe, but supply constraints don’t fix that or target illegitimate prescriptions, they just make it (well, until all supply is exhausted, then everyone is SOL) a lottery for every patient, regardless of legitimacy of their prescription. It adds a whole new problem, rather than solving the notionally motivating problem, and it is so obvious that this is the case that either the people adopting the policy are the biggest fucking idiots in the world, or the policy is outright malicious and not directed at the problem that supposedly justifies it. (Since its part of the War on Drugs, the second option is guaranteed to be part of it.) |